20 reports

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Cancer
  • Cell Therapy
  • Therapy
  • Bristol-Myers Squibb Company

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Cancer
  • Cell Therapy
  • Therapy
  • Bristol-Myers Squibb Company

One patient had a fatal SAE, which was not drug related.

  • Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Alkaloid Drugs is one important part of Cervical Cancer Treatment Drugs in China.

  • Cancer
  • China
  • Eli Lilly & Co.
  • Hubei HONCH Pharmaceutical Co., Ltd.
  • Jiangsu Hansoh Pharmaceutical Co., Ltd
  • Cervical Cancer Treatment Drugs Production and Demand
  • Cervical Cancer Treatment Drugs Production and Demand

Alkaloid Drugs is one important part of Cervical Cancer Treatment Drugs in China.

  • Cancer
  • China
  • Hubei HONCH Pharmaceutical Co., Ltd.
  • Jiangsu Hansoh Pharmaceutical Co., Ltd
  • Ltd Shanghai Richem International Co.

Sanofi also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women' s health; and vitamins, minerals and supplements.

  • Cancer
  • Hospital
  • Immunotherapy
  • Therapy
  • MediciNova, Inc.

THE ALLERGY AND IMMUNOLOGY CENTER IS HOME TO NATIONALLY AND INTERNATIONALLY RENOWNED EXPERTS AND RESEARCHERS WHO ARE ON THE FOREFRONT OF EVALUATING NEW METHODS OF ALLERGY TESTING AND TREATMENT, AND PAVING THE WAY IN THE FIELDS OF FOOD ALLERGY, DRUG

  • Cancer
  • Hospital
  • Medical Device
  • Respiratory Device
  • Market Size
  • JTE-852 - DRUG PROFILE

One patient had a fatal SAE, which was not drug related.

  • Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

URTICARIA PIGMENTOSA IS AN ALLERGY-MEDIATED RASH COMMON IN SM PATIENTS.

  • Cancer
  • Dermatological Condition
  • Hospital
  • Therapy
  • United States

The company is focuses in the areas of oncology, allergy and immunology, and urology.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Meiji Seika Pharma Co., Ltd.

HOWEVER, THIS MODEL HAS RESULTED IN MANY APPROVED COMPANION DIAGNOSTIC TESTS THAT CAN MEASURE ONE ANALYTE (DRUG TARGET, ETC. ) AT A TIME.

  • Cancer
  • Health Services
  • Molecular Diagnostics
  • United States
  • Company

The company offers a wide range of drugs including drugs for pain, inflammation, and allergies; drugs for urological diseases; drugs for hematologic malignancies; drugs for gastrointestinal disorders; drugs for cardiovascular and metabol

  • Cancer
  • Pathology
  • Therapy
  • United States
  • Product Initiative

The company offers a wide range of drugs including drugs for pain, inflammation, and allergies; drugs for urological diseases; drugs for hematologic malignancies; drugs for gastrointestinal disorders; drugs for cardiovascular and metabol

  • Cancer
  • Therapy
  • United States
  • Company Operations
  • Product Initiative

In November 2015, Taiho Pharmaceutical Co., Ltd announced that it has submitted an application for approval of the manufacture and marketing of TAC-## (bilastine), an oral anti-allergy drug, to the Japanese Ministry of Health, Labour and Welfare.

  • Cancer
  • Chemotherapy
  • Pharmaceutical
  • Product Initiative
  • Taiho Pharmaceutical Co., Ltd.

Fluticasone furoate can be used to treat both seasonal allergies and allergies that occur all year long (known as perennial allergies).

  • Cancer
  • Respiratory Device
  • Vaccine
  • United States
  • GlaxoSmithKline plc

ANAVEX ##-## is an oral drug candidate that targets sigma-## and muscarinic receptors.

  • Biomarker
  • Cancer
  • Genomics
  • United States
  • Roche Group

R& D Progress Research and Development Brief SMALL MOLECULE TO INHIBIT IGE FOR ALLERGIES Product Description IgE inhibitor is under development of the treatment of allergy.

  • Cancer
  • Research And Development
  • Japan
  • Company Operations
  • Interprotein Corporation

One example is the breast cancer drug trastuzumab (Herceptin).

  • Cancer
  • United States
  • Company
  • Company Operations
  • QIAGEN N.V.

Talizumab was under development for the treatment of peanut allergy.

  • Cancer
  • Monoclonal Antibody
  • United States
  • Company Operations
  • Genentech, Inc.

In September 2014, National Institute of Allergy and Infectious Diseases in collaboration with Immune Tolerance Network (ITN) registered a Phase I/ II study of AMG-## to find out if cat allergy shots with combination with AMG- ##, an experimental medication, will help the cat

  • Blood Disease
  • Cancer
  • Monoclonal Antibody
  • Therapy
  • Amgen Inc.